H4S 1Z6, Montreal, QC,
Canada
Abbott Canada Technographics
Abbott Canada Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Abbott Canada and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1500 Abbott Canada employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Abbott Canada has purchased the following applications: Nucleus Security Platform for Vulnerability Management in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Abbott Canada is running and its propensity to invest more and deepen its relationship with Nucleus Security or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Abbott Canada revenues, which have grown to $250.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Abbott Canada intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Abbott Canada Tech Stack and Enterprise Applications
Abbott Canada CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Nucleus Security | Legacy | Nucleus Security Platform | Vulnerability Management | CyberSecurity | n/a | 2021 | 2021 |
In 2021 Abbott Canada implemented Nucleus Security Platform for Vulnerability Management as part of an APOC focused cybersecurity program at the Abbott Laboratories Ottawa site, with activity spanning September 2021 through December 2024. The deployment was led within the GRC cybersecurity analyst function and prioritized incident response and vulnerability assessment workflows to prevent audit findings for Abbott Point of Care.
The Nucleus Security Platform implementation included configuration of vulnerability assessment workflows and classification logic, with the team developing and publishing two critical standard operating procedures for incident response and vulnerability assessment. Functional capabilities exercised included vulnerability discovery and triage, severity and criticality classification, mitigation recommendation tracking, and user acceptance testing for dashboarded data flows.
Integrations were explicit and operational, the implementation assessed and classified vulnerabilities using Qualys and Nucleus, relied on ARMIS for network visibility and asset risk assessment, and maintained accurate asset and configuration data in a ServiceNow CMDB. Nucleus Security Platform was used alongside these tools to centralize vulnerability findings and to feed ARMIS dashboard data integration tests, supporting cybersecurity, IT operations, and compliance workflows across the APOC scope.
Governance and process changes centered on formalizing SOPs, embedding vulnerability assessment steps into the ServiceNow driven CMDB lifecycle, and ensuring controls were monitored for effectiveness. Activities included research, peer consultation, and training to maintain awareness of threat and regulatory trends, and the work explicitly aimed to prevent audit findings while ensuring ongoing compliance to applicable cybersecurity controls.
|
IT Decision Makers and Key Stakeholders at Abbott Canada
Apps Being Evaluated by Abbott Canada Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||